Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010
Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Respiratory response to hypercapnic stimulation in hypercapnic obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Respiratory responses to chemical stimulation in normocapnic and hypercapnic patients with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 418s Year: 2006
Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA). Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 322s Year: 2002
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Normocapnia in obstructive sleep apnoea versus hypoventilation in obesity: respiratory drive makes the difference Source: International Congress 2019 – Obesity: pathophysiology, diagnostic challenges and multidisciplinary treatment Year: 2019